Sernova Biotherapeutics (HAM:PSH0) Cyclically Adjusted Book per Share: €0.03 (As of Apr. 2026)


HAM:PSH0 Sernova Biotherapeutics Inc HAM:PSH0
31 GF Score
Price €0.08
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics Cyclically Adjusted Book per Share?

Sernova Biotherapeutics HAM:PSH0 +1.95% 31 Cyclically Adjusted Book per Share is €0.03 as of Apr. 2026. GuruFocus rates HAM:PSH0 with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Sernova Biotherapeutics's adjusted book value per share for the three months ended in Apr. 2026 was €-0.036. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.03 for the trailing ten years ended in Apr. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -7.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 6.20% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Sernova Biotherapeutics was 18.60% per year. The lowest was -17.00% per year. And the median was 0.00% per year.

As of today (2026-07-08), Sernova Biotherapeutics's current stock price is €0.0836. Sernova Biotherapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Apr. 2026 was €0.03. Sernova Biotherapeutics's Cyclically Adjusted PB Ratio of today is 2.79.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sernova Biotherapeutics was 3.63. The lowest was 0.00. And the median was 0.00.


Sernova Biotherapeutics  (HAM:PSH0) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sernova Biotherapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.0836/0.03
=2.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sernova Biotherapeutics was 3.63. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Sernova Biotherapeutics Cyclically Adjusted Book per Share Related Terms


Sernova Biotherapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Sernova Biotherapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics Cyclically Adjusted Book per Share Chart

Sernova Biotherapeutics Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.03

Sernova Biotherapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.03 0.02 0.03

HAM:PSH0 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Sernova Biotherapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova Biotherapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Cyclically Adjusted PB Ratio falls into.


HAM:PSH0
31GF Score
Sernova Biotherapeutics Inc HAM:PSH0
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sernova Biotherapeutics's adjusted Book Value per Share data for the three months ended in Apr. 2026 was:

Adj_Book= Book Value per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=-0.036/132.7364*132.7364
=-0.036

Current CPI (Apr. 2026) = 132.7364.

Sernova Biotherapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201607 0.023 101.844 0.030
201610 0.024 102.002 0.031
201701 0.023 102.318 0.030
201704 0.022 103.029 0.028
201707 0.019 103.029 0.024
201710 0.015 103.424 0.019
201801 0.013 104.056 0.017
201804 0.010 105.320 0.013
201807 0.016 106.110 0.020
201810 0.014 105.952 0.018
201901 0.011 105.557 0.014
201904 0.008 107.453 0.010
201907 0.007 108.243 0.009
201910 0.017 107.927 0.021
202001 0.013 108.085 0.016
202004 0.007 107.216 0.009
202007 0.005 108.401 0.006
202010 0.013 108.638 0.016
202101 0.027 109.192 0.033
202104 0.081 110.851 0.097
202107 0.078 112.431 0.092
202110 0.075 113.695 0.088
202201 0.082 114.801 0.095
202204 0.066 118.357 0.074
202207 0.113 120.964 0.124
202210 0.116 121.517 0.127
202301 0.107 121.596 0.117
202304 0.072 123.571 0.077
202307 0.052 124.914 0.055
202310 0.028 125.310 0.030
202401 0.009 125.072 0.010
202404 -0.012 126.890 -0.013
202407 -0.028 128.075 -0.029
202410 -0.027 127.838 -0.028
202501 -0.037 127.443 -0.039
202504 -0.040 129.102 -0.041
202507 -0.047 130.290 -0.048
202510 -0.046 130.603 -0.047
202601 -0.046 130.366 -0.047
202604 -0.036 132.736 -0.036

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.03 mean?
Sernova Biotherapeutics (HAM:PSH0) has a Cyclically Adjusted Book per Share of €0.03 as of Apr. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sernova Biotherapeutics and its competitors.
Is Sernova Biotherapeutics' Cyclically Adjusted Book per Share too high?
Sernova Biotherapeutics' current Cyclically Adjusted Book per Share is €0.03. Overall, Sernova Biotherapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' Cyclically Adjusted Book per Share compare to VRTX and REGN?
Sernova Biotherapeutics' Cyclically Adjusted Book per Share of €0.03 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sernova Biotherapeutics and its competitors. Sernova Biotherapeutics's current Cyclically Adjusted Book per Share is €0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (HAM:PSH0) has a current Cyclically Adjusted Book per Share of €0.03. The current Cyclically Adjusted Book per Share is €0.03. Sernova Biotherapeutics' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Sernova Biotherapeutics (HAM:PSH0), the current Cyclically Adjusted Book per Share is €0.03 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
31GF Score

Get the complete analysis for HAM:PSH0

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.08
Price